AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$11.010
Hoch
$11.400
Tief
$10.940
Volumen
3.47M
Unternehmensfundamentaldaten
Marktkapitalisierung
3.6B
Branche
Drug Manufacturers - Specialty & Generic
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
1.66M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.